CapsoVision, Inc. (CV) vs Opus Genetics, Inc. (IRD)
A side-by-side comparison of CapsoVision, Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.47HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
IRD
Opus Genetics, Inc.
$4.40HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CV vs IRD
growth of $100 · dividends reinvested · last 1yCV +88.3% (+88.3%/yr)IRD +342.4% (+342.4%/yr)IRD compounded faster over this window
CV IRD
CV vs IRD: by the numbers
- •IRD is the larger company ($363M vs $323M market cap).
- •Both run net losses; CV's is the smaller (-214.74% vs -1091.82% net margin).
Metrics side by side
Valuation
| Metric | CV | IRD |
|---|---|---|
| P/S ratio | 23.28 | 36.82 |
| P/B ratio | 24.57 | N/A |
Profitability
| Metric | CV | IRD |
|---|---|---|
| Gross margin | 50.88% | 99.87% |
| Operating margin | -188.25% | -271.90% |
| Net margin | -214.74% | -1091.82% |
| ROE | -226.56% | N/A |
| ROIC | -164.32% | -59.29% |
Growth (annualized)
| Metric | CV | IRD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 150.49% |
Go deeper
Dig into the metrics
CapsoVision ROEOpus Genetics ROECapsoVision operating marginOpus Genetics operating marginCapsoVision revenue growthOpus Genetics revenue growthCapsoVision free cash flowOpus Genetics free cash flow
CapsoVision & Opus Genetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.